Detection of isoforms and genomic alterations by high- 1 throughput full-length single-cell RNA sequencing for 2 personalized oncology 3

Abstract

[1]  I. Melero,et al.  Cancer vaccines: the next immunotherapy frontier , 2022, Nature Cancer.

[2]  D. Stekhoven,et al.  scROSHI: robust supervised hierarchical identification of single cells , 2022, bioRxiv.

[3]  Jonathan M. Mudge,et al.  A joint NCBI and EMBL-EBI transcript set for clinical genomics and research , 2022, Nature.

[4]  Hagen U. Tilgner,et al.  Single-nuclei isoform RNA sequencing unlocks barcoded exon connectivity in frozen brain tissue , 2022, Nature Biotechnology.

[5]  C. Vollmers,et al.  Single-cell isoform analysis in human immune cells , 2022, Genome biology.

[6]  L. Chin,et al.  A functional genomic approach to actionable gene fusions for precision oncology , 2022, Science advances.

[7]  Ö. Türeci,et al.  Identification of neoantigens for individualized therapeutic cancer vaccines , 2022, Nature Reviews Drug Discovery.

[8]  J. Banchereau,et al.  A comprehensive long-read isoform analysis platform and sequencing resource for breast cancer , 2022, Science advances.

[9]  D. Hanahan.  Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[10]  Y. Shiraishi,et al.  Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer , 2021, Communications Biology.

[11]  E. Banks,et al.  High-throughput RNA isoform sequencing using programmable cDNA concatenation , 2021, bioRxiv.

[12]  Mark D. Robinson,et al.  Doublet identification in single-cell sequencing data using scDblFinder , 2021, F1000Research.

[13]  Gail Dutton,et al.  CRISPR-Cas9 Technology Cuts Clutter from Sequencing Libraries , 2021, Genetic Engineering & Biotechnology News.

[14]  A. Cribbs,et al.  Nanopore sequencing of single-cell transcriptomes with scCOLOR-seq , 2021, Nature Biotechnology.

[15]  N. Beerenwinkel,et al.  scAmpi—A versatile pipeline for single-cell RNA-seq analysis from basics to clinics , 2021, bioRxiv.

[16]  Jia Wei,et al.  Gene fusion neoantigens: Emerging targets for cancer immunotherapy. , 2021, Cancer letters.

[17]  Beryl B. Cummings,et al.  Transcriptome variation in human tissues revealed by long-read sequencing , 2021, Nature.

[18]  Stephen R. Williams,et al.  A spatially resolved brain region- and cell type-specific isoform atlas of the postnatal mouse brain , 2021, Nature Communications.

[19]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[20]  J. Arenas,et al.  Altered Expression Ratio of Actin-Binding Gelsolin Isoforms Is a Novel Hallmark of Mitochondrial OXPHOS Dysfunction , 2020, Cells.

[21]  A. Gonzalez-Perez,et al.  A compendium of mutational cancer driver genes , 2020, Nature Reviews Cancer.

[22]  Xiaochen Bo,et al.  HIT-scISOseq: High-throughput and High-accuracy Single-cell Full-length Isoform Sequencing for Corneal Epithelium , 2020, bioRxiv.

[23]  J. Valcárcel,et al.  Roles and mechanisms of alternative splicing in cancer — implications for care , 2020, Nature Reviews Clinical Oncology.

[24]  Jianhua Zhang,et al.  Tumor Suppressor microRNA-138 Suppresses Low-Grade Glioma Development and Metastasis via Regulating IGF2BP2 , 2020, OncoTargets and therapy.

[25]  Jack Kuipers,et al.  The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support. , 2020, Cancer cell.

[26]  F. Dilworth,et al.  The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance , 2019, Oncogene.

[27]  M. Guan,et al.  The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis , 2019, iScience.

[28]  M. Zavolan,et al.  PolyASite 2.0: a consolidated atlas of polyadenylation sites from 3′ end sequencing , 2019, Nucleic Acids Res..

[29]  Funding Information , 2019, The Art Bulletin.

[30]  P. Agius,et al.  Immunogenic neoantigens derived from gene fusions stimulate T cell responses , 2019, Nature Medicine.

[31]  R. Satija,et al.  Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression , 2019, Genome Biology.

[32]  G. Tseng,et al.  Identification of recurrent fusion genes across multiple cancer types , 2019, Scientific Reports.

[33]  Mengzhong Liu,et al.  ALK Inhibitors in the Treatment of ALK Positive NSCLC , 2019, Front. Oncol..

[34]  Paul J. Hoover,et al.  Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma , 2019, Cell.

[35]  Lai Guan Ng,et al.  Dimensionality reduction for visualizing single-cell data using UMAP , 2018, Nature Biotechnology.

[36]  Mark Gerstein,et al.  GENCODE reference annotation for the human and mouse genomes , 2018, Nucleic Acids Res..

[37]  Ahmed Mahfouz,et al.  Single-cell isoform RNA sequencing characterizes isoforms in thousands of cerebellar cells , 2018, Nature Biotechnology.

[38]  Steven J. M. Jones,et al.  Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients , 2018, Cancer cell.

[39]  Elaine R. Mardis,et al.  The emerging clinical relevance of genomics in cancer medicine , 2018, Nature Reviews Clinical Oncology.

[40]  Li Ding,et al.  Driver Fusions and Their Implications in the Development and Treatment of Human Cancers , 2018, Cell reports.

[41]  R. Meijering,et al.  IGF system targeted therapy: Therapeutic opportunities for ovarian cancer. , 2017, Cancer treatment reviews.

[42]  Oliver Hofmann,et al.  Copy-number signatures and mutational processes in ovarian carcinoma , 2017, Nature Genetics.

[43]  F. Welch,et al.  Causes and Consequences , 2017, Nature.

[44]  Lennart Martens,et al.  1 SQANTI : extensive characterization of long read transcript sequences for quality control in 1 full-length transcriptome identification and quantification 2 3 , 2017 .

[45]  Paul W Dickman,et al.  Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  N. Bertin,et al.  A resource of ribosomal RNA-depleted RNA-Seq data from different normal adult and fetal human tissues , 2015, Scientific Data.

[47]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[48]  Sean C. Bendall,et al.  Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis , 2015, Cell.

[49]  B. Johansson,et al.  The emerging complexity of gene fusions in cancer , 2015, Nature Reviews Cancer.

[50]  T. Schumacher,et al.  Neoantigens in cancer immunotherapy , 2015, Science.

[51]  J. George,et al.  Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. , 2014, The Journal of clinical investigation.

[52]  M. Koutsilieris,et al.  The Complexity of the IGF1 Gene Splicing, Posttranslational Modification and Bioactivity , 2014, Molecular medicine.

[53]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[54]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[55]  E. Lander,et al.  Lessons from the Cancer Genome , 2013, Cell.

[56]  Xuetao Cao,et al.  Tespa1 is involved in late thymocyte development through the regulation of TCR-mediated signaling , 2012, Nature Immunology.

[57]  J. Akey.  Analysis of 2,440 human exomes highlights the evolution and functional impact of rare coding variation , 2011, Genome Biology.

[58]  K. Hebelstrup,et al.  UCE: A uracil excision (USER™)-based toolbox for transformation of cereals , 2010, Plant Methods.

[59]  Gurpreet W. Tang,et al.  The Catalogue of Somatic Mutations in Cancer , 2009 .

[60]  T. Whiteside.  The tumor microenvironment and its role in promoting tumor growth , 2008, Oncogene.

[61]  D. Katsaros,et al.  IGF-I in epithelial ovarian cancer and its role in disease progression , 2007, Growth factors.

[62]  B. Blencowe.  Alternative Splicing: New Insights from Global Analyses , 2006, Cell.

[63]  Ash A. Alizadeh,et al.  SUPPLEMENTARY NOTE , 1879, Botanical Gazette.

[64]  S. Egyházi Brage,et al.  BRAF inhibitors in cancer therapy. , 2014, Pharmacology & therapeutics.

[65]  Sven Rahmann,et al.  Genome analysis , 2022 .

[66]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[67]  J. Paul,et al.  New Dimensions , 2011 .